Wellbutrin

A May 2010 study published in the American Journal of Obstetrics and Gynecology found that children born to women taking Wellbutrin during the first trimester of pregnancy are twice as likely to be born with a form of heart defects. Researchers found that these children were at an increased risk of developing left outflow tract defects, which affect the flow of blood from the left chambers of the heart to the rest of the body.

Wellbutrin was approved by the Food and Drug Administration in 1985 to treat the symptoms of depression. The drug was briefly withdrawn in 1986 due to an increased risk of seizures when taken at high doses, but was later allowed back on the market in lower dose form. Wellbutrin’s active ingredient, bupropion, is also found in the drug Zyban, which is prescribed as a stop smoking aid.

According to the study, the most common form of heart defect among children born to mothers taking Wellbutrin during pregnancy was coarctation of the aorta, a narrowing of the main artery in the body, which often requires surgery. Other forms of left outflow defects that may be caused by Wellbutrin include aortic stenosis, ventricular septal defects (VSD), aortic septal defects (ASD), hypoplastic left heart syndrome, pulmonary stenosis, Tetralogy of Fallot or other side effects.

If your child was born with left outflow tract defects or other birth defects after you used Wellbutrin while pregnant, contact the lawyers at Hissey Kientz, LLP for a free evaluation. You can reach our attorneys by calling toll-free at 1-866-275-4454, or by filling out the free case evaluation form on the right of this page.

I am currently represented by an attorney
*Required fields